Related Experiment Video
Updated: Aug 29, 2026

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling
Published on: October 28, 2014
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
Aaron D Schimmer1, Kate Welsh, Clemencia Pinilla
1The Burnham Institute, La Jolla, CA 92037, USA.
Abstract:
Apoptosis resistance commonly occurs in cancers, preventing activation of Caspase family cell death proteases. XIAP is an endogenous inhibitor of Caspases overexpressed in many cancers. We developed an enzyme derepression assay, based on overcoming XIAP-mediated suppression of Caspase-3, and screened mixture-based combinatorial chemical libraries for compounds that reversed XIAP-mediated inhibition of Caspase-3, identifying a class of polyphenylureas with XIAP-inhibitory activity. These compounds, but not inactive structural analogs, stimulated increases in Caspase activity, directly induced apoptosis of many types of tumor cell lines in culture, and sensitized cancer cells to chemotherapeutic drugs. Active compounds also suppressed growth of established tumors in xenograft models in mice, while displaying little toxicity to normal tissues. These findings validate IAPs as targets for cancer drug discovery.
Insights
Researchers identified polyphenylureas that inhibit XIAP, a protein overexpressed in cancers that blocks cell death. These compounds promote cancer cell death and reduce tumor growth, validating IAPs as drug targets.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Cancer cells often resist apoptosis, a key cell death pathway.
- X-linked inhibitor of apoptosis protein (XIAP) is an endogenous caspase inhibitor overexpressed in many cancers, contributing to apoptosis resistance.
Purpose of the Study:
- To identify novel compounds that overcome XIAP-mediated caspase inhibition.
- To validate Inhibitor of Apoptosis Proteins (IAPs) as therapeutic targets for cancer treatment.
Main Methods:
- Development of an enzyme derepression assay to screen for XIAP inhibitors.
- Screening of mixture-based combinatorial chemical libraries.
- In vitro testing of compound efficacy on cancer cell lines and in vivo xenograft models.
Main Results:
- Identification of a class of polyphenylureas with XIAP-inhibitory activity.
- Active compounds increased caspase activity, induced apoptosis in tumor cell lines, and sensitized cells to chemotherapy.
- Compounds suppressed tumor growth in mouse xenograft models with minimal toxicity to normal tissues.
Conclusions:
- Polyphenylureas effectively inhibit XIAP and promote cancer cell death.
- IAPs represent a promising target class for the development of novel cancer therapeutics.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Extrinsic Apoptotic Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...